Agreed - spot on @dplane
"since no drug is ever perfectly safe or effective, the FDA is tasked with
determining when the benefits of a drug outweigh its disadvantages. On an even more challenging level, the FDA is forced to predict whether the future benefits of a drug will outweigh its future disadvantages. If the FDA is too conservative in approving new drugs, then
consumers are denied access to much-needed medicines, however, if the FDA is too liberal in approving new drugs, then consumers will be exposed to risky medicines. It is in striking a balance between these two extremes that the FDA reviews drug applications to approve or deny new drug applications, thereby affecting these drugs’ availability in the market."
How well did the FDA perform their task/ function in this instance with Ryoncil?
Surely, if we can see this, then someone with higher authority at the FDA can see this as well.
Way way way too officious!
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-8271
-
- There are more pages in this discussion • 4,800 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.101B |
Open | High | Low | Value | Volume |
96.5¢ | 99.5¢ | 96.0¢ | $2.283M | 2.340M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29300 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29300 | 0.965 |
12 | 149369 | 0.960 |
4 | 49283 | 0.955 |
8 | 162786 | 0.950 |
3 | 79500 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 20000 | 1 |
0.975 | 25589 | 3 |
0.980 | 119783 | 8 |
0.985 | 23639 | 4 |
0.990 | 105300 | 7 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |